As of 2024-12-15, the EV/EBITDA ratio of Sensyne Health PLC (SENS.L) is 0.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SENS.L's latest enterprise value is -4.80 mil GBP. SENS.L's TTM EBITDA according to its financial statements is -35.75 mil GBP. Dividing these 2 quantities gives us the above SENS.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 8.8x | 6.4x |
| Forward P/E multiples | 6.5x - 10.5x | 8.6x |
| Fair Price | (63.44) - (86.69) | (73.46) |
| Upside | -18226.5% - -24869.2% | -21089.7% |
| Date | EV/EBITDA |